PROCEDURAL SOLUTIONS
Uterine fibroids account for 30% of the 600,000 women who undergo hysterectomies annually.1 Uterine fibroid embolization (UFE) is a minimally invasive alternative to hysterectomy or myomectomy.
TransRadial Artery Access (TRA) is proven to reduce associated bleeding and vascular complications. Using TRA in embolization procedures conveys proven benefits such as same day discharge opportunities, reduction in major bleeding complications, a readily accessible and easy to manage access site, and improved patient satisfaction.2-5
Terumo Interventional Systems is equipped to support your UFE procedure from access to embolization to closure.
Keep your patients in mind as you embolize. The unique formulation of HYDROPEARL Microspheres was exclusively developed to offer controlled and targeted embolization. HYDROPEARL Microspheres are tightly calibrated and indicated for embolization of uterine fibroids. This precise calibration may allow more predictable and targeted embolization.6-8
Learn more about Terumo's full portfolio of embolization solutions
In addition to uniquely-designed radial access solutions, Terumo offers industry-leading professional education for peripheral procedures. Build upon your success from coronary and cultivate new skills by implementing radial access as a best practice.
Embolization treatment options in the management of pelvic venous disease/pelvic congestion syndrome as well as transradial uterine fibroid embolization (TRUFE).
This study investigates the feasibility of performing uterine artery embolization (UAE) via transradial access (TRA).
Comparing clinical and technical outcomes of transradial (TRA) uterine artery embolization (UAE) with those of the transfemoral (TFA) approach.
Assessing feasibility and rate of patients returning to the hospital when a same-day discharge protocol is used for patients undergoing transradial uterine artery embolization (UAE) for symptomatic fibroids.
